JPMorgan says there's a strong likelihood the FDA is going to approve Amarin's (AMRN) high...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

JPMorgan says there's a strong likelihood the FDA is going to approve Amarin's (AMRN) high triglyceride drug AMR101 when it meets on Thursday. Based on the approval, the firm sees a fair price for the shares of around $22 by the end the year. Expect some volatility on the way however, the last time the stock hit those levels was clear back in 2007.